Orexigen Therapeutics, Inc. Files Registration Statement for Proposed Follow-On Offering

SAN DIEGO--(BUSINESS WIRE)--Orexigen™ Therapeutics, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed offering of 7,000,000 shares of common stock. Certain selling stockholders expect to grant the underwriters a 30-day option to purchase an additional 1,050,000 shares to cover over-allotments, if any.
MORE ON THIS TOPIC